Cardiometabolic Disease / Type 2 Diabetes
Indication
Type 2 Diabetes
Assets addressing this indication.
Total attributable cost
$324.6B
$12,022/patient
Drug spend
$126.1B
$4,670/patient
39% of total cost is drugs
All severities · US
Cardiometabolic Disease / Type 2 Diabetes
Indication
Assets addressing this indication.
Total attributable cost
$324.6B
$12,022/patient
Drug spend
$126.1B
$4,670/patient
39% of total cost is drugs
All severities · US
128 of 128 assets